Trial intelligence / Profile preview

Memantine in Frontotemporal Dementia

NCT00200538Phase 2Completed

Sponsor
CHU de Nantes
Start
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of memantine in frontotemporal dementia (FTD), sponsored by CHU de Nantes. Started Sep 2005; status: completed.

02

Drugs

memantine
03

Conditions

frontotemporal dementia (FTD)

Beyond the preview

Go deeper on NCT00200538.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00200538.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call